Once again Alcyomics will be attending the PEGS Summit to be held next week in Boston.
Whilst at the event we will be running two poster sessions, in addition to Dr Ahmed giving a talk on Monday 1st May within the Cellular Therapies Stream. The talk is titled Human in vitro Skin Explant Assays for Predicting Immunotoxicity of Drugs and Cellular Therapies. Dr Ahmed will discuss how Skimune® can be used as a screening service for biological drugs, as well as small molecule drugs to predict immunotoxicity, and also cellular therapies.
Dr Ahmed will run a poster session on Thursday to cover the topic once more.
On Monday Louis Bibby will be running a poster session titled Predicting Adverse Immune Reactions to Biopharmaceuticals Using Skimune®, a Human in vitro Skin Explant Test: A Novel Tool for Biopharmaceutical Research & Development.
The poster gives detail of the Skimune® Mab assay and how it can be used for predicting adverse immune reactions to biological drugs, as well as Skimune® 3D model and how that can also be used in the same manner.
For more information on the PEGS Summit please visit http://www.pegsummit.com/ and if you are in the area, please come along to discuss any requirements that you may have or just to find out more about the services that we can offer.